Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 4 Jan 21 424B4 Prospectus supplement with pricing info
- 31 Dec 20 EFFECT Notice of effectiveness
- 29 Dec 20 FWP Free writing prospectus
-
29 Dec 20 S-1/A IPO registration (amended)
- 18 Dec 20 S-1 IPO registration
HSTO similar filings
Filing view
External links
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated March 11, 2020 (except for the effects of the reverse stock split discussed in Note 1, as to which the date is December 18, 2020) in Amendment No. 1 to the Registration Statement (Form S-1 No. 333-251491) and related Prospectus of Histogen Inc. (formerly Conatus Pharmaceuticals Inc.) for the registration of its common stock and common warrants to purchase common stock.
/s/ Ernst & Young LLP
San Diego, California
December 29, 2020